1. Liberek T, Topley N, Jörres A, Petersen MM, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron. 1993;65:260–5.
2. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Williams RK, Mackenzie GT, Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470–9.
3. Linden T, Forsbäck G, Deppisch R, Henle T, Wieslander A. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int. 1998;18:290–3.
4. Jörres A, Topley N, Witowski J, Liberek T, Gahl GM. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int. 1993;13:S291–4.
5. Douvdevani A, Rapoport J, Konforty A, Yulzari R, Moran A, Chaimovitz C. Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol. 1995;6:207–13.